经导管主动脉瓣置换的介入瓣膜的现状及展望(PDF)
《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]
- 期数:
- 2012年第1期
- 页码:
- 127-137
- 栏目:
- 综述
- 出版日期:
- 2012-02-25
文章信息/Info
- Title:
- Present and future use of transcatheter valve for transcatheter aortic valve replacement therapies
- Author(s):
- WANG Jian-ming; YANG Jian; YI Ding-hua
- （Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China）
- 关键词:
- 主动脉瓣; 经导管主动脉瓣置换术; 介入瓣膜
- 分类号:
- R322.11
- DOI:
- -
- 文献标识码:
- A
- 摘要:
- 经导管主动脉瓣置换术（TAVR）经过最近几年快速发展已经取得巨大进步。迄今为止全球接受TAVR的患者数已近3万例，已成为无法耐受传统手术患者的标准备选治疗措施。从目前已临床应用的介入瓣膜到正在实验研究的新型介入瓣膜可以看出，未来介入瓣膜的发展目标是尺寸更小、长期有效、安全性高、并发症少、操作简单及定位精准。随着TAVR的推广，新型介入瓣的研发，操作者经验的积累，以及长期随访的开展，将给TAVR提供更科学的病例选择标准，减少介入手术的相关并发症，提高更安全有效的治疗效果。未来此项技术还会逐渐扩大适用人群的范围，成为代替传统的主动脉瓣置换术举足轻重的治疗措施。
- Abstract:
- Tremendous progress has been made in transcatheter aortic valve replacement (TAVR) therapies in recent years and TAVR has become an alternative treatment to surgical aortic valve replacement (AVR), with nearly 30 000 procedures performed to date worldwide. Clinical application and investigation of transcatheter valves signify that the future transcatheter valve system will be targeted towards low-profile sheath, long-term efficacy, and safe and precise placement. With wider application and development of transcatheter valves, cumulative experiences and long-term follow-up of TAVR therapies, better criteria will be established for patient selection. Complications will be reduced and safer and more effective treatment results will be achieved. TAVR therapies will be applied to a larger subset of patients and become an important alternative to future conventional aortic valve replacement.
参考文献/References
[1]贺 强,杨 剑,易定华.经导管主动脉瓣植入法和支架主动脉瓣的发展[J].心脏杂志,2010,22(3):461-464.
[2]Vahanian A,Baumgartner H,Bax J,et al.Task force on the management of valvular heart disease of the european society of cardiology; ESC committee for practice guidelines.Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology[J].Eur Heart J,2007,28(2):230-268.
[3]Kolh P,Kerzmann A, Honore C,et al.Aortic valve surgery in octogenarians: predictive factors for operative and long term results[J].Eur J Cardiothorac Surg,2007,31(4): 600-606.
[4]Chiam PT,Ruiz CE. Percutaneous transcatheter aortic valve implantation: evolution of the technology[J].Am Heart J, 2009,157(2):229-242.
[5]Piazza N,Grube E,Gerckens U,et al.Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system:results from the multicentre, expanded evaluation registry 1-year following CE mark approval[J].EuroIntervention,2008,4(2):242-249.
[6]Khawaja MZ,Haworth P,Ghuran A,et al. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements[J].J Am Coll Cardiol,2010,55(2):97-101.
[7]Piazza N,de Jaegere P,Schultz C, et al. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve[J].Circ Cardiovasc Intervent,2008,1(1):74-81.
[8]Dewey TM,Brown D,Ryan WH,et al.Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement[J].J Thorac Cardiovasc Surg,2008,135(1):180-187.
[9]Vahanian A,Alfieri O,Al-Attar N,et al.Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio- Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)[J].Eur Heart J,2008,29(11):1463-1470.
[10]Osswald BR,Gegouskov V,Badowski-Zyla D,et al.Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement[J].Eur Heart J,2009,30(1):74-80.
[11]Bleiziffer S,Ruge H,Mazzitelli D,et al.Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team[J].Eur J Cardiothorac Surg,2009,35(4):615-620.
[12]Grube E,Schuler G,Buellesfeld L,et al.Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current thirdgeneration self-expanding CoreValve? prosthesis: device success and 30-day clinical outcome[J].Cardiology,2007,50(1):69-76.
[13]Piazza N,Grube E,Gerckens U,et al.Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval[J].EuroIntervention,2008,4(2):242-249.
[14]Grube E,Buellesfeld L,Mueller R,et al. Progress and current status of percutaneous aortic valve replacement: results of threedevice generations of the CoreValve? revalving system[J].Circ Cardiovasc Intervent,2008,1(3):167-175.
[15]Tamburino C,Capodanno D,Mulè M,et al.Procedural success and 30?day clinical outcomes after percutaneous aortic valve replacement using current thirdgeneration self-expanding CoreValve? prosthesis[J].J Invasive Cardiol,2009,21(3):93-98.
[16]Wenaweser P,Buellesfeld L,Gerckens U,et al.Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Core-valve Revalving system[J].Catheter Cardiovasc Interv,2007,70(5):760-764.
[17]Ruiz CE,Laborde JC,Condado JF,et al.First percutaneous transcatheter aortic valve-in-valve implant with three year follow-up[J].Catheter Cardiovasc Interv,2008,72(2):143-148.
[18]Webb JG,Chandavimol M,Thompson CR,et al. Percutaneous aortic valve implantation retrograde from the femoral artery[J].Circulation, 2006, 113(6):842-850.
[19]Webb JG,Altwegg L,Masson JB,et al.A new transcatheter aortic valve and percutaneous valve delivery system[J].J Am CollCardiol,2009,53(20):1855-1858.
[20]Webb JG, Altwegg L,Boone RH,et al.Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes[J].Circulation,2009,119(23):3009-3016.
[21]Ye J,Cheung A,Lichtenstein SV, et al.Transapical transcatheter aortic valve implantation:1-year outcome in 26 patients[J].J Thorac Cardiovasc Surg,2009,137(1):167-173.
[22]Noble S,lbrahim R,Basmadjian A,et al. Paravalvular leak following surgical valve replacement: is there a role for percutaneous paravalvular leak reduction?[J].Rev Med Suisse,2010,6(251):1154-1158.
[23]Ussia GP,Mulè M,Tamburino C.The valve-in-valve technique: transcatheter treatment of aortic bioprothesis malposition[J].Catheter Cardiovasc Interv,2009,73(5):713-716.
[24]Piazza N,Schultz C,de Jaegere P, et al. Implantation of two self-expanding aortic bioprosthetic valves during the same procedure-Insights into valve-in-valve implantation (“Russian doll concept”)[J].Catheter Cardiovasc Interv,2009,73(4):530-539.
[25]Serruys PW.Transcatheter aortic valve implantation:state of the art[J].EuroIntervention,2009,4(5):558-565.
[26]Grube E,Laborde JC,Gerckens U,et al.Percutaneous implantation of the Core Valve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study[J].Circulation,2006,114(15):1616-1624.
[27]Webb JG,Pasupati S,Humphries K,et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis[J].Circulation,2007,116(7):755-763.
[28]Sinhal A,Altwegg L,Pasupati S,et al.Atrioventricular block after transcatheter balloon expandable aortic valve implantation[J].JACC Cardiovasc Interv,2008,1(3):305-309.
[29]Piazza N,Onuma Y,Jesserun E,et al.Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve[J].JACC Cardiovasc Interv,2008,1(3):310-316.
[30]Piazza N,Grube E,Gerckens E,et al.Procedural and 30-days outcomes following transcatheter aortic valve implantation using the third generation (18F) Corevalve revalving system. Results from the multicenter, expanded evaluation registry 1-year following CE mark approval[J].EuroIntervention,2008,4(2):242-249.
[31]Grube E,Schuler G,Buellesfeld L,et al.Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome[J].J Am Coll Cardiol,2007,50(1):69-76.
[32]Buellesfeld L,Gerckens U,Grube E.Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis[J].Catheter Cardiovasc Interv,2008,71(5):579-584.
[33]Low RI, Bolling SF,Yeo KK,et al.Direct flow percutaneous aortic valve: proof of concept[J].EuroIntervention,2008,4(2):256-261.
[34]Schofer J,Schlüter M,Treede H,et al. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study[J].Circ Cardiovasc Intervent,2008,1(2):126-133.
[35]Treede H,Tübler T, Reichenspurner H,et al.Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement:The Direct Flow Medical aortic valve[J].J Thorac Cardiovasc Surg,2010,140(4):897-903.
[36]Tamburino C,Barbanti M,Capodanno D,et al.Transcatheter aortic valve implantation: what has been done and what is going to be done[J].Future Cardiol,2010,6(1):83-95.
[37]Del Valle-Fernández R,Martinez CA,Ruiz CE.Transcatheter aortic valve implantation[J].Cardiol Clin,2010,28(1):155-168.
[38]Lauten A,Ferrari M,Petri A,et al.Experimental evaluation of the JenaClip transcatheter aortic valve[J].Circ Cardiovasc Intervent,2009,74(3):514-519.
[39]Falk V,Schwammenthal EE,Kempfert J,et al.New anatomically oriented transapical aortic valve implantation[J].Ann Thorac Surg,2009,87(3):925-926.
[40]Vergnat M,Henaine R,Kalejs M,et al.A new self-expanding aortic stent valve with annular fixation: in vitro haemodynamic assessment[J].Eur J Cardiothorac Surg,2009,35(6):970-975.
备注/Memo
- 备注/Memo:
- 收稿日期：2011-09-25.通讯作者：杨剑，副教授,主要从事心血管外科疾病的介入治疗研究 Email:yangjian1212@hotmail.com 作者简介：王建铭，硕士生 Email:cyrusaaaa@hotmail.com
常用功能
统计/Statistics
- 摘要浏览/Viewed1207
- 全文下载/Downloads580
- 评论/Comments
